Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|January 8, 1987
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trialJ W Eschbach, J C Egrie, M R Downing, et al.
American Journal of Hypertension|December 1, 1990
Hypertension following erythropoietin therapy in anemic hemodialysis patientsF S Buckner, J W Eschbach, N R Haley, et al.
The New England Journal of Medicine|July 20, 1989
Treatment of the anemia of progressive renal failure with recombinant human erythropoietinJ W Eschbach, M R Kelly, N R Haley, et al.
Kidney International|June 9, 2000
Mechanisms for the formation of glycoxidation products in end-stage renal diseaseM F Weiss, P Erhard, F A Kader-Attia, et al.
Clinical Pharmacology and Therapeutics|November 1, 1980
Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidneyP D Mitnick, A Greenberg, P B DeOreo, et al.
Clinical Nephrology|February 1, 1993
Effects of erythropoietin on strength and functional status of patients on hemodialysisM Guthrie, D Cardenas, J W Eschbach, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1990
Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patientsH T Robertson, N R Haley, M Guthrie, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 30, 2000
Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: description, findings, and implicationsE P Steinberg, G Eknoyan, N W Levin, et al.
Artificial Organs|February 1, 1978
Uremic neuropathy: evidence of middle molecule toxicityJ Milutinovic, A L Babb, J W Eschbach, et al.
Clinical Nephrology|July 1, 1997
Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patientsT B Drüeke, P Bárány, M Cazzola, et al.
Pageof 5